| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8698 |
| Human Intestinal Absorption | HIA+ | 0.9823 |
| Caco-2 Permeability | Caco2+ | 0.9221 |
| P-glycoprotein Substrate | Non-substrate | 0.5133 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6117 |
| Non-inhibitor | 0.6352 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8542 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5314 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8061 |
| CYP450 2D6 Substrate | Non-substrate | 0.8956 |
| CYP450 3A4 Substrate | Non-substrate | 0.5861 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9692 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5811 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8248 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.5383 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.5703 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5765 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9394 |
| Non-inhibitor | 0.9522 |
| AMES Toxicity | AMES toxic | 0.6196 |
| Carcinogens | Non-carcinogens | 0.9244 |
| Fish Toxicity | High FHMT | 0.8503 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9719 |
| Honey Bee Toxicity | High HBT | 0.8686 |
| Biodegradation | Not ready biodegradable | 0.5285 |
| Acute Oral Toxicity | III | 0.5457 |
| Carcinogenicity (Three-class) | Non-required | 0.5640 |